Dahlman T, Lindvall N, Hellgren M
Department of Obstetrics and Gynaecology, Karolinska Hospital, Stockholm, Sweden.
Br J Obstet Gynaecol. 1990 Mar;97(3):221-8. doi: 10.1111/j.1471-0528.1990.tb01785.x.
Osteopenia, sometimes with compression fractures of the spine, is a side-effect of long-term heparin treatment. The frequency is unknown. In this study, 70 women were given subcutaneous heparin as therapy for, or prophylaxis against, thromboembolism during pregnancy. All, except two, were examined by X-ray of the spine and hip first week post partum. The duration of treatment and the dosage of heparin varied. There were 12 (17%) with obvious osteopenia, including two women with multiple fractures of the spine (3%). Re-examination 6-12 months post partum showed that the changes were reversible in most cases. Another 18 women were examined about three years after heparin treatment during pregnancy. No obvious osteopenia was found among them or in a control group of 30 women examined in the first week post partum. The degree of osteopenia was not correlated with either the heparin dose or the duration of treatment. Women treated with heparin in consecutive pregnancies do not seem to have an increased risk of osteopenia.
骨质减少,有时伴有脊柱压缩性骨折,是长期肝素治疗的一种副作用。其发生率尚不清楚。在本研究中,70名女性在孕期接受皮下注射肝素治疗或预防血栓栓塞。除两名女性外,其余所有女性在产后第一周均接受了脊柱和髋部X线检查。治疗时间和肝素剂量各不相同。有12名女性(17%)出现明显骨质减少,其中两名女性有多处脊柱骨折(3%)。产后6 - 12个月的复查显示,大多数情况下这些变化是可逆的。另外18名女性在孕期肝素治疗约三年后接受了检查。在她们以及产后第一周接受检查的30名女性组成的对照组中均未发现明显骨质减少。骨质减少的程度与肝素剂量或治疗时间均无关联。连续孕期接受肝素治疗的女性似乎不存在骨质减少风险增加的情况。